Faith Group

Endovascular therapies are reshaping the Arteriovenous Malformation Market. Advanced embolization devices and catheter-based techniques allow precise treatment with minimal complications.

These therapies reduce hospital stays, improve recovery rates, and enhance patient safety. Growing adoption in developed and emerging regions is driving market expansion and fueling continuous technological improvements.

Market Outlook: The global market, worth USD 1.1 billion in 2024, is projected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.